Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? The "BedMed-Frail" Randomized Controlled Trial

NCT04054648 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT04054648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04054648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? The "BedMed-Frail" Randomized Controlled Trial
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2020
Completion date
February 29, 2024
Enrollment
776 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, hypertension